drug protocol number

GBT2104-131

drug sponsor

Global Blood Therapeutics, Inc.

drug study

Inclacumab

drug trial site

Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia , Qatif Central Hospital

drug status

Ongoing

drug phase